Avanos Medical (AVNS) Accounts Payables (2013 - 2026)

Avanos Medical's Accounts Payables history runs 14 years deep, the most recent figure standing at $52.3 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 13.7% year-over-year to $52.3 million; the TTM figure through Mar 2026 stood at $52.3 million (up 13.7% YoY), while the FY2025 annual figure was $55.5 million, up 2.21% from the prior year.
• Accounts Payables came in at $52.3 million for Q1 2026 at Avanos Medical, down from $55.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $67.9 million in Q4 2022 to a low of $46.0 million in Q1 2025.
• A 5-year average of $56.8 million and a median of $55.5 million in 2025 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables increased 20.39% in 2022 and decreased 21.41% in 2024, its largest moves.
• Avanos Medical's Accounts Payables stood at $67.9 million in 2022, then slipped by 17.08% to $56.3 million in 2023, then retreated by 3.55% to $54.3 million in 2024, then gained by 2.21% to $55.5 million in 2025, then declined by 5.77% to $52.3 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $52.3 million, $55.5 million, and $54.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison